Peripheral Artery Thrombosis clinical trials at UCLA
1 research study open to eligible people
Showing trials for
JETi Peripheral Thrombectomy Registry
open to eligible people ages 18 years and up
The JETi Registry is a prospective, single-arm, multi-center study to collect real-world data on the safety, performance, and clinical benefits of the JETi® Peripheral Thrombectomy System (JETi System) for the treatment of acute/subacute thrombosis in the peripheral vasculature. This post-market study will register approximately 280 subjects at approximately 30 centers in the US and Europe. Subjects participating in this registry will be followed through their 12-month follow up visit.
Los Angeles, California and other locations
Last updated: